Optinose_logo_RGB.png
Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results
February 29, 2024 16:40 ET | Optinose, Inc.
YARDLEY, Pa., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Arbutus Biopharma Logo
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
February 29, 2024 07:30 ET | Arbutus Biopharma Corporation
On-track to report key clinical data in 2024 from two on-going Phase 2a clinical trials with imdusiran and the Phase 1a/1b clinical trial with AB-101 Plans to initiate a third Phase 2a clinical...
image1 (1).png
Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations
February 29, 2024 07:30 ET | Evaxion Biotech
COPENHAGEN, Denmark, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
mining_logo_mux_2019.jpg
McEwen Mining 2023 Results Conference Call
February 28, 2024 13:57 ET | McEwen Mining
TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) invites you to join our conference call following the release of our Q4 and year-end 2023 financials results on...
MacroGenics-Logo-(transparent-background).png
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
February 27, 2024 17:45 ET | MacroGenics, Inc.
ROCKVILLE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
Chris Jackson, CEO of CyberloQ Technologies, Inc. and Luis Tujillo, Founder and Managing Partner of PAARC Consulting Outline the Evolution of Fraud in the Payments Industry and Their Efforts to Stop It
February 22, 2024 08:30 ET | SmallCapVoice.com and CyberloQ Technologies, Inc.
This in-depth conversation sheds light on their innovative strategies to combat cyber fraud, highlighting the impactful partnership between the two.
life.jpg
LifeVantage to Participate in the Winter Wrap Up MicroCap Rodeo Conference
February 16, 2024 08:00 ET | LifeVantage Corporation
SALT LAKE CITY, Feb. 16, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the...
blk_parkerlogo.jpg
Parker Scheduled to Present at Barclays 41st Annual Industrial Select Conference on February 21 at 10:20 a.m. Eastern Time
February 15, 2024 17:00 ET | Parker-Hannifin Corporation
CLEVELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at the...
Arbutus Biopharma Logo
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
February 15, 2024 07:30 ET | Arbutus Biopharma Corporation
WARMINSTER, Pa., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
Agios_2021_Logo.png
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
February 15, 2024 07:00 ET | Agios Pharmaceuticals, Inc.
Agios reports fourth quarter and full year 2023 financial results and recent business highlights